News 2016-04-29
Vice Governor of Zhejiang Province Visits Porton Shangyu Site.
The vice governor of Zhejiang Province, Xiong Jianping, accompanied by other government officials visits Porton Shangyu Site on April 28th, 2016.
The president, Andrew Xu, give a presentation on Porton’s general situation, EHS conception, development planning, R&D investment and high-level Hardware facilities investment.
The vice governor and officials visit workshop, wastewater treatment facility and RTO equipment, give fully affirmation and admiration to the implement of international standard production facility design, investment and management. On the environmental protection aspect, source control, fully enclosed vertical flow workshop design, automation control and etc. are highly accepted by the governor.
The vice governor show to the entourage after on-the-spot investigation at Porton Shangyu Site, if other company operated according to Porton’s conception and management style, he is confidence on garden’s tail gas treatment and control. He also mentioned that the company could be better if they are willing to input, choose better equipment and excellent management.
Others
MoreNews 2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News 2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.